Max Healthcare Institute Limited (MAXHEALTH) — Announcement | 13 August 2026(2 announcements)

Max Healthcare Institute reported Q1 FY27 revenue of ₹2,982 Cr, up 16% YoY, with EBITDA at ₹704 Cr (+15% YoY) and PAT of ₹357 Cr. It acquired controlling stakes in Kalinga Hospital and Yerawada Properties, approved ₹425 Cr capital expenditure for a new hospital tower, and added 202 beds. Operational metrics show 75% bed occupancy, 10% YoY growth in occupied bed days, and ₹81.9k ARPOB (+5% YoY). The company also entered medical education with in-principle approval and expanded its network to 60+ cities. Strategic acquisitions and capacity expansion underpin growth, supported by strong cash generation of ₹397 Cr from operations.

The Board approved unaudited Q1 FY2026 results showing revenue of ₹78,292 lakhs and profit of ₹22,591 lakhs, while announcing key management changes including appointments of Ajay Vij and Pawan Kumar Marella and Dr. N. Venkatesan's resignation effective August 31, 2026. Capital expenditure of up to ₹425 Crore was cleared for hospital expansion, alongside approvals for new medical colleges and MoA amendments. The filing also disclosed acquisitions of Kalinga Hospital and Yerawada Properties, and dissolution of the Nigerian subsidiary, marking strategic shifts in leadership and growth focus.